Our study systematically discusses the association between KIF18A and transcription level, clinical prognosis, TME, tumor mutational load (TMB), microsatellite instability (MSI), mismatch repair (MMR), and DNA and RNA methylation in 33 cancers, providing strategies and directions for future research on KIF18A-based anti-tumor therapy. Here, KIF18A is linked to cancer.